BioMarin Pharmaceutical, Inc. (BMRN)
53.23
-0.86
(-1.59%)
USD |
NASDAQ |
May 26, 10:00
BioMarin Pharmaceutical Market Cap : 10.29B for May 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 12.48B |
| Alnylam Pharmaceuticals, Inc. | 39.67B |
| BridgeBio Pharma, Inc. | 13.19B |
| Mirum Pharmaceuticals, Inc. | 6.012B |
| Cytokinetics, Inc. | 10.38B |
Market Cap Related Metrics
| PE Ratio | 38.84 |
| PS Ratio | 3.153 |
| Price to Book Value | 1.656 |
| Price to Free Cash Flow | 13.66 |
| Price | 53.23 |
| Earnings Yield | 2.57% |
| Operating PE Ratio | 14.07 |
| Normalized PE Ratio | 19.41 |